📰 Program Updates News
Page 13 - Program Updates News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Program Updates. Real-time updates on events, politics, business and more.
May 8, 2023
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline ... | May 8, 2023
April 13, 2023
Breaking news headlines about Lyme Disease linking to 1,000s of websites from around the world
April 11, 2023
Moderna Announces Clinical and Program Updates at 4th Vaccines Day
March 29, 2023
Completed enrollment of the Phase 2 PEAK Trial of AVTX-002 in non-eosinophilic asthma ; topline data expected in the second quarter of 2023Disclosed cash of approximately $13 million as of... | March 29, 2023
March 29, 2023
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
March 28, 2023
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated... | March 28, 2023
March 28, 2023
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect...
March 23, 2023
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
March 23, 2023
Enrollment progressing in Phase 1b Multiple-Ascending Dose (MAD) study of RGLS8429 in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Top-line data in the first cohort of RGLS8429-treated ADPKD patients anticipated in second half of ...
March 7, 2023
Company expands precision oncology pipeline with licensing of CRB-701, clinical-stage Nectin-4 antibody drug conjugate (ADC) from CSPC Pharmaceutical Group CRB-701 Phase 1 dose escalation ongoing in